Join us on January 28th for our 2026 North American Industrial Market Outlook. Register Now!
Sales & Support: +1 800 762 3361
Member Resources
Industrial Info Resources Logo
Global Market Intelligence Constantly Updated Your Trusted Data Source for Industrial & Energy Market Intelligence
Home Page

Advanced Search

Reports related to this article:


Released February 12, 2020 | GALWAY, IRELAND
en
Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Botox maker Allergan plc (NYSE:AGN) (Dublin, Ireland) has opened a new 160 million-euro ($177 million) biologics plant in Westport, County Mayo, Ireland.

The Biologics 2 facility will create 63 jobs, bringing the company's Irish workforce to more than 2,000 and cementing its position as the strategic global hub for Allergan's flagship products, in particular Botox. To date, the company has invested more than 750 million euro ($829 million) in its Irish operations. Allergan operates four facilities in Ireland, two manufacturing operations at Clonshaugh in Dublin and Westport as well as an international supply chain office in Dublin and a facility in Galway following the acquisition of Zeltiq in 2017.

The Biologics 2 facility at Allergan Westport will have new manufacturing suites and feature a new state-of-the-art microbiology and cell-based laboratory to support "the next generation of biologics innovation." The opening coincided with the shipping of the 100 millionth vial of Botox from the Westport campus, 30 years after the product first received FDA approval.

The opening was attended by Ireland's Minister for Rural and Community Development Michael Ring. "Allergan's further expansion is a vote of confidence in Mayo and the West," he said. "Speaking as someone from Westport, Allergan has had a remarkably positive impact on the town and on the region. This announcement is further evidence of how the West can provide a wonderful environment for investors and employers. I commend Allergan for putting their trust in the West of Ireland. With the new N5 road project from Turlough to Westport taking shape, our ability to attract investment and jobs into the region will only improve."

Wayne Swanton, executive vice president of global operations at Allergan plc, said: "It gives me great pride to mark the global opening of our Biologics 2 facility here in Westport as we embark on the next chapter of growth and innovation for Allergan's botulinum toxin brand and other biologics products. The sensitivity of biologics in the manufacturing process is like no other. It requires a level of exactness in manufacturing and handling throughout the whole supply chain around the world, which is truly unique. That journey starts here in Westport on the west coast of Ireland with a team of over 1,300 passionate and highly skilled people who have been integral to growing our products to the scale we see today and delivering impact for patients."

He added: "Throughout our 40 years here in Ireland, we have enjoyed a tremendous relationship with local, regional and national government and the community around us. We continue to believe Ireland is an outstanding country for investment and expansion for all our products that are manufactured here in Westport. Ireland has made education, training and investment in its biopharma workforce a priority. As we look to the future, it is one of the benefits we value tremendously from having such a strong presence here in Ireland."

Industrial Info is tracking two Irish Allergan projects. At the Clonshaugh Alzheimer's oral solid dose plant in Dublin, which encompasses two manufacturing facilities and company HQ, the company is expanding its upgrading and equipping laboratories and the manufacturing campus to increase specialized manufacturing capability for new solid dose products currently in development. In Westport, at its ocular implant facility, Allergan is introducing automated manufacturing processes using high-end robotics. It claims the new technology will create products with the "potential to revolutionise the treatment of common eye conditions such as glaucoma."

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Our European headquarters are located in Galway, Ireland. Follow IIR Europe on: Facebook - Twitter - LinkedIn For more information on our European coverage send inquiries to info@industrialinfo.eu or visit us online at Industrial Info Europe.

IIR Logo Globe

Site-wide Scheduled Maintenance for September 27, 2025 from 12 P.M. to 6 P.M. CDT. Expect intermittent web site availability during this time period.

×
×

Contact Us

For More Info!